Home  /  Resource Library  /  Real-world outcomes after CAR T versus standard therapy in third-line or later relapsed or refractory follicular lymphoma in the United States

Real-world outcomes after CAR T versus standard therapy in third-line or later relapsed or refractory follicular lymphoma in the United States

Real world study investigated CAR-T therapy for treatment of relapsed follicular lymphoma.